omniture
logo
Search
Aston Sci. Inc.
Media Room

Latest News

rss

Aston Sci. Receives IND Approval from U.S. FDA for Phase 2 Clinical Trial of the Therapeutic Cancer Vaccine AST-301 in Patients with HER2 1+/2+ Breast Cancer

- CornerStone-001(NCT05163223), the multiregional clinical trial for breast cancer treatment, recei...

2022-09-05 07:00 1883